The NewStatesman invited leading oncologists, patient groups including Melanoma UK CEO, Gillian Nuttall, and experts in public health to Westminster to discuss immune-oncology’s potential, and how this transformative technology can become ‘business as usual’ within the NHS.

To read the article please click the link below.